EP1906969A4 - Methods for treating and diagnosing complications of premature birth - Google Patents

Methods for treating and diagnosing complications of premature birth

Info

Publication number
EP1906969A4
EP1906969A4 EP06787681A EP06787681A EP1906969A4 EP 1906969 A4 EP1906969 A4 EP 1906969A4 EP 06787681 A EP06787681 A EP 06787681A EP 06787681 A EP06787681 A EP 06787681A EP 1906969 A4 EP1906969 A4 EP 1906969A4
Authority
EP
European Patent Office
Prior art keywords
treating
methods
premature birth
complications
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06787681A
Other languages
German (de)
French (fr)
Other versions
EP1906969A2 (en
Inventor
Judah Folkman
Anne Hansen
Carmen Barnes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of EP1906969A2 publication Critical patent/EP1906969A2/en
Publication of EP1906969A4 publication Critical patent/EP1906969A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP06787681A 2005-07-15 2006-07-17 Methods for treating and diagnosing complications of premature birth Withdrawn EP1906969A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69977905P 2005-07-15 2005-07-15
PCT/US2006/027808 WO2007011926A2 (en) 2005-07-15 2006-07-17 Methods for treating and diagnosing complications of premature birth

Publications (2)

Publication Number Publication Date
EP1906969A2 EP1906969A2 (en) 2008-04-09
EP1906969A4 true EP1906969A4 (en) 2009-07-29

Family

ID=37669506

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06787681A Withdrawn EP1906969A4 (en) 2005-07-15 2006-07-17 Methods for treating and diagnosing complications of premature birth

Country Status (5)

Country Link
EP (1) EP1906969A4 (en)
JP (1) JP2009501729A (en)
AU (1) AU2006269994A1 (en)
CA (1) CA2614677A1 (en)
WO (1) WO2007011926A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980952B2 (en) 2002-03-20 2015-03-17 University Of Maryland, Baltimore Methods for treating brain swelling with a compound that blocks a non-selective cation channel
JP4485806B2 (en) 2002-03-20 2010-06-23 ユニヴァーシティ オブ メリーランド，ボルチモア Non-selective cation channels and brain swelling of neural cells
EP2359832A3 (en) 2004-09-18 2011-11-23 University of Maryland, Baltimore Therapeutic agents targeting the NCCA-ATP channel and methods of use thereof
EP3103451A1 (en) 2007-01-12 2016-12-14 University of Maryland, Baltimore Targetting ncca-atp channel for organ protection following ischemic episode
US8518877B2 (en) 2007-04-18 2013-08-27 Premacure Ab Method and product for treatment and/or prevention of complications of prematurity
CA2974689C (en) * 2007-06-22 2020-02-25 The United States Of America As Represented By The Department Of Veters Affairs Inhibitors of ncca-atp channels for therapy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643900A (en) * 1993-07-02 1997-07-01 Fotsis; Theodore Method for treatment of pathological conditions associated with angiogenesis and preparation therefor
US20020002294A1 (en) * 1997-09-24 2002-01-03 D' Amato Robert J. Estrogenic compounds as antiangiogenic agents
US20020147183A1 (en) * 2000-08-18 2002-10-10 Agoston Gregory E. Antiangiogenic agents
US20030181531A1 (en) * 2003-02-11 2003-09-25 David Sherris Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998395B2 (en) * 2001-08-17 2006-02-14 University Of Pittsburg, Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643900A (en) * 1993-07-02 1997-07-01 Fotsis; Theodore Method for treatment of pathological conditions associated with angiogenesis and preparation therefor
US20020002294A1 (en) * 1997-09-24 2002-01-03 D' Amato Robert J. Estrogenic compounds as antiangiogenic agents
US20020147183A1 (en) * 2000-08-18 2002-10-10 Agoston Gregory E. Antiangiogenic agents
US20030181531A1 (en) * 2003-02-11 2003-09-25 David Sherris Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MIYAMOTO NORIKO ET AL: "Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE JUN 2002, vol. 43, no. 6, June 2002 (2002-06-01), pages 2007 - 2014, XP002531882, ISSN: 0146-0404 *
MOOBERRY SUSAN L: "Mechanism of action of 2-methoxyestradiol: New developments.", DRUG RESISTANCE UPDATES, vol. 6, no. 6, December 2003 (2003-12-01), pages 355 - 361, XP002531883, ISSN: 1368-7646 *
STAFFORD S J ET AL: "Colchicine and 2-methoxyestradiol Inhibit Human Angiogenesis", JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC., SAN DIEGO, CA, US, vol. 125, no. 1, 1 May 2005 (2005-05-01), pages 104 - 108, XP004843113, ISSN: 0022-4804 *
TROTTER A ET AL: "Effects of postnatal estradiol and progesterone replacement in extremely preterm infants", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, ENDOCRINE SOCIETY, CHEVY CHASE, MD, vol. 84, no. 12, 1 December 1999 (1999-12-01), pages 4531 - 4535, XP002254227, ISSN: 0021-972X *

Also Published As

Publication number Publication date
EP1906969A2 (en) 2008-04-09
WO2007011926A2 (en) 2007-01-25
JP2009501729A (en) 2009-01-22
WO2007011926A3 (en) 2007-03-22
AU2006269994A1 (en) 2007-01-25
CA2614677A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
EP2029743A4 (en) Methods of diagnosing and treating complications of pregnancy
EP1811844A4 (en) Methods for diagnosis and treatment of cancer
IL225386A0 (en) Diagnosis and treatment of cancer using anti-ereg antibody
EP1969147A4 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers
EP1945754A4 (en) Compositions and methods for treating and diagnosing cancer
IL197721A0 (en) Compositions and methods for diagnosing and treating cancer
EP2032166A4 (en) Compositions and methods for diagnosing and treating cancer
HK1179275A1 (en) Compositions and methods for diagnosing and treating cancer
ZA200808865B (en) Antibody composition and methods for treatment of neoplastic disease
IL187238A0 (en) Compositions and methods for treating hyperproliferative epidermal diseases
EP2050466A4 (en) Diagnosis and treatment of cancer using anti-desmoglein-3 antibody
EP2171086A4 (en) Methods of diagnosing and treating cancer
GB0608647D0 (en) Methods of diagnosis and treatment
EP1890537A4 (en) Methods of treating cancer and other conditions or disease states using lfmau and ldt
EP1951908A4 (en) Fgf2-related methods for diagnosing and treating depression
EP1869212A4 (en) Use of id4 for diagnosis and treatment of cancer
EP1906969A4 (en) Methods for treating and diagnosing complications of premature birth
ZA200808363B (en) Compounds and methods for diagnosis and treatment of leishmaniasis
EP1909809A4 (en) Method and compositions for the treatment of diabetes and related complications
IL192031A0 (en) Use of cicletanine and other furopyridines for treatment of hypertension
EP2099491A4 (en) Compositions and methods for diagnosing and treating cancer
EP2099933A4 (en) Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
EP1718294A4 (en) Methods for treatment of complications of diabetes
IL198425A0 (en) Method of diagnosing and treating glioma
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080115

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HANSEN, ANNE

Inventor name: BARNES, CARMEN

Inventor name: FOLKMAN, JUDAH

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/56 20060101AFI20070326BHEP

Ipc: A61P 43/00 20060101ALI20090617BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20090626

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090925